References
- Brodie BB, Axelrod J. The fate of acetanilide in man. J Pharmacol Exp Ther 1948; 94:29–38.
- Mitchell J, Jollow D, Potter W, Gilette J, Brodie BB. Acetaminophen-induced hepatic necrosis. Protective role of glutathione. J Pharmacol Exp Ther 1973; 187:211–217.
- Prescott LF, Roscoe P, Wright N, Brown S. Plasma paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage. Lancet 1971; 1:519–522.
- Prescott LF, Stewart MJ, Proudfoot AT. Cysteamine or N-acetylcysteine for paracetamol poisoning? Br Med J 1978; 1:856–857.
- Prescott LF, Roscoe P, Wright N, Brown SS. Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage. Lancet 1971; 1:519–522.
- Rumack BH, Matthew H. Acetaminophen poisoning and toxicity. Pediatrics 1975; 55:871–876.
- Prescott LF, Illingworth RN, Critchley JA, Stewart MJ, Adam RD, Proudfoot AT. Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning. Br Med J 1979; 2:1097–1100.
- Smilkstein MJ, Knapp GL, Kulig KW, Rumak BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicentre study (1976 to 1985). NEJM 1988; 319:1557–1562.
- Joint Formulary Committee. British National Formulary. 61 ed. BMJ Group & RPS Publishing; 2010:34–36.
- Daly FF, Fountain JS, Murrary L, Graudins A, Buckley NA. Guidelines for the management of paracetamol poisoning in Australia and New Zealand – explanation and elaboration. MJA 2008; 188:296–301.
- Bateman DN, Dear J. Medicine, poison and mystic potion: a personal perspective on paracetamol Louis Roche lecture, Stockholm, 2009. Clin Toxicol 2010; 48:97–103.
- Beer C, Pakravan N, Hudson M, Smith LT, Simpson K, Bateman DN, Thomas SHL. Liver unit admission following paracetamol overdose with concentrations below current UK treatment thresholds. QJM 2007; 100:93–96.
- Prescott LF. Gastrointestinal absorption of drugs. Med Clin North Am 1974; 58:907–916.
- Anderson BJ, Monteleone J, Holdford NH. Variability of concentrations after rectal paracetamol. Paediatr Anaesth 1998; 8:274.
- Anderson BJ, Woolard GA, Holdford NH. Pharmocokinetics of rectal paracetamol after major surgery in children. Paediatr Anaesth 1995; 5:237–242.
- Bilenko N, Tessler H, Okbe R, Press J, Gorodischer R. Determinants of anti-pyretics misuse in children up to 5 years of age: a cross-sectional study. Clin Ther 2006; 28:783–793.
- Clements JA, Prescott LF. Data point weighting in pharmacokinetic analysis: intravenous paracetamol in man. J Pharm Pharmacol 1976; 28:707–709.
- Clements JA, Critchley JA, Prescott LF. The role of sulphate conjugation in the metabolism and disposition of oral and intravenous paracetamol in man. Br J Clin Pharmacol 1984; 18:481–485.
- MHRA. Granted Marketing Authorisations (MAs) published in January 2003, MHRA, 2003. http://www.mhra.gov.uk/home/groups/l-reg/documents/licensing/con026458.pdf. Accessed 21 February 2011.
- ADEC. The Commonwealth of Australia Gazette. Commonwealth of Australia; 2004. http://www.ag.gov.au/Portal/govgazonline.nsf/2C43959049D61398CA2577980009A422/$file/GN%2035.pdf. Accessed 21 February 2011.
- Macario A, Royal MA. A literature review of randomized clinical trials of intravenous acetaminophen (paracetamol) for acute postoperative pain. Pain Pract 2010; article first published online 28 November 2010.
- Bektas F, Eken C, Karadeniz O, Goksu E, Cubuk M, Cete Y. Intravenous paracetamol or morphine for the treatment of renal colic: a randomized, placebo-controlled trial. Ann Emerg Med 2009;54:568–574.
- Duggan ST, Scott LJ. Intravenous paracetamol (acetominophen). Drugs 2009; 69:101–113.
- Beringer RM, Thomson JP, Parry S, Stoddart PA. Intravenous paracetamol overdose: two case reports and a change to national treatment guidelines. Arch Dis Child 2011; 96:307–308.
- Nevin D, Shung J. Intravenous paracetamol overdose in a preterm infant during anaesthesia. Pediatr Anesth 2010; 20:105–114.
- NPSA. Overdose of intravenous paracetamol in infants and children Signal. NHS National Patient Safety Agency; 2010 [Reference No 1293F]. http://www.nrls.npsa.nhs.uk/resources/type/signals/?entryid45=83757. Accessed 21 February 2011.
- Campello-Iddison V. Direct healthcare professional communication on serious cases of accidental overdose reported in infants and children with intravenous paracetamol 10 mg/ml solution for infusion. Bristol Myers; 2010. http://www.mhra.gov.uk/home/groups/pl-p/documents/websiteresources/con081749.pdf. Accessed 21 February 2011.
- Wong IC, Ghaleb MA, Franklin BD, Barber N. Incidence and nature of dosing errors in paediatric medications: a systematic review. Drug Saf 2004; 27:661–670.
- Cubie AM. Determination into the causes of death of Danielle Welsh. Sheriffdom of Glasgow and Strathkelvin; 2011. http://www.scotcourts.gov.uk/opinions/2011FAI7.html. Accessed 21 February 2011.
- Rawlins MD, Henderson DB, Hijab AR. Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration. Eur J Clin Pharmacol 1977; 11:283–286.
- Allegaert K, Palmer GM, Anderson BJ. The pharmacokinetics of intravenous paracetamol in neonates: size matters most. Arch Dis Child 2011; article first published online 13 February 2011.
- FDA. Highlights of Perscribing Information Ofirmev (Acetaminophen) Injection. 2010. http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022450lbl.pdf. Accessed 21 February 2011.
- TGA. IV paracetamol – where does it sit in hospital practice? New South Wales Therapeutic Advisory Group Inc; 2005. http://www.ciap.health.nsw.gov.au/nswtag/publications/posstats/IVparacetamol.pdf. Accessed 21 February 2011.
- MHRA. Drug Safety Advice, Intravenous paracetamol - risk of accidental overdose, especially in infants and neonates. MHRA & CHM; 2010. http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON088171. Accessed 21 February 2011.